The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Lilly; Roche
Speakers' Bureau - Bayer; Eisai; Ipsen
Research Funding - Bayer (Inst); BMS Brazil (Inst); Lilly (Inst); MSD (Inst); Roche (Inst)
 
Speakers' Bureau - AstraZeneca; Bayer Health; Bristol-Myers Squibb; Celgene; Eisai; Falk Foundation; Ipsen; MSD; Novartis; Roche Pharma AG; SERVIER; Shire; Sirtex Medical
Travel, Accommodations, Expenses - Bayer Health; Celgene; Ipsen; Novartis; Sirtex Medical
Cabozantinib in advanced hepatocellular carcinoma: Efficacy and safety data from an international multicenter real-world cohort.
 
Fabian Finkelmeier
Travel, Accommodations, Expenses - Abbvie; Ipsen
 
Bernhard Scheiner
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences
 
Catherine Leyh
No Relationships to Disclose
 
Jan Best
Consulting or Advisory Role - BMS Brazil; BTG; Eisai; MSD; Roche
Speakers' Bureau - BTG; Eisai; Novartis
Travel, Accommodations, Expenses - BMS Brazil; BTG; Ipsen
 
Thorben Wilhelm Fründt
No Relationships to Disclose
 
Carolin Czauderna
No Relationships to Disclose
 
Alica Beutel
No Relationships to Disclose
 
Dominik Bettinger
Consulting or Advisory Role - Bayer Health; Boston Scientific; Falk Foundation
 
Johannes Weiß
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Falk Foundation; Gilead Sciences; Ipsen; MSD; Novartis
Research Funding - MSD (Inst)
 
Tobias Meischl
No Relationships to Disclose
 
Fabian Kuetting
Honoraria - Bayer; Eisai; Ipsen; MSD
Consulting or Advisory Role - Bayer; Eisai; Ipsen; MSD; Sirtex Medical
Speakers' Bureau - Bayer; Eisai; Ipsen; MSD
Travel, Accommodations, Expenses - Eisai; Janssen; SERVIER
 
Dirk Thomas Waldschmidt
No Relationships to Disclose
 
Michael Schultheiß
Consulting or Advisory Role - Bayer; Falk Foundation
 
Thomas Jens Ettrich
Consulting or Advisory Role - Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Lilly; Merck Serono; MSD; MSD; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi/Aventis
Research Funding - Baxalta/Shire
Travel, Accommodations, Expenses - Ipsen; Ipsen
 
Arndt Weinmann
No Relationships to Disclose
 
Henning Wege
No Relationships to Disclose
 
Marino Venerito
Honoraria - Bayer; Merck Serono; Nordic Bioscience
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Ipsen; Lilly; MSD; Nordic Bioscience
Research Funding - Sirtex Medical
Expert Testimony - Lilly
 
Christian Lange
Consulting or Advisory Role - Abbvie; CSL Behring; Eisai; Falk Foundation; Gilead Sciences; MSD; Norgine; Roche
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences
 
Matthias Pinter
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Lilly; MSD; Roche
Speakers' Bureau - Bayer; BMS Brazil; Eisai; MSD
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bayer; BMS Brazil
 
Oliver Waidmann
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Eisai; Falk Foundation; Ipsen; Merck; MSD; Novartis; Roche; Servier; Shire
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Celgene; Eisai; Falk Foundation; Ipsen; Merck Serono; MSD; Novartis; Roche; Servier; Shire
Research Funding - Merck Serono
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb; Ipsen; Medac; Merck Serono